Monthly Archives

January 2019

2019 Annual Health Summit & Legislative Day

  • January 30, 2019
  • Justin Bost

Join Family Voices of California at the 2019 Annual Health Summit & Legislative Day, on March 10-12, 2019, to hear from experts and... Continue Reading

Emmaus Life Sciences Launches Its Commercial Co-Payment Assistance Program for Endari™

  • January 28, 2019
  • Justin Bost

TORRANCE, Calif., Jan. 28, 2019 /PRNewswire/ — Emmaus Life Sciences, Inc. (Emmaus), a leader in sickle cell disease treatment, announced today that... Continue Reading

WEBINAR TODAY: Introducing the Blueprint for Complex Care: Opportunities to Advance the Field

  • January 22, 2019
  • Justin Bost

Introducing the Blueprint for Complex Care: Opportunities to Advance the Field WEBINAR Date: January 22, 2019 Time: 2:00 pm- 3:00 pm... Continue Reading

ASGCT Society Patient Education Program

  • January 18, 2019
  • Justin Bost

The American Society of Gene & Cell Therapy (ASGCT) is proud to announce the first release of the Society’s Patient Education program, a new initiative... Continue Reading

47th Annual National Convention Call for Abstracts

  • January 18, 2019
  • Justin Bost

If you are you a researcher, community-based member organization, physician, nurse, social worker or someone working on behalf of people with... Continue Reading

47th Annual National Convention Theme Announced

  • January 18, 2019
  • Justin Bost

Sickle Cell Disease Association of America, Inc. is pleased to announce the theme for the 47th Annual National Convention: Sickle Cell Community... Continue Reading

SCDAA Hires New Director of Development & Special Initiatives

  • January 9, 2019
  • Justin Bost

Baltimore City native, Gary Bonner, will serve as the Director of Development & Special Initiatives. In this capacity, Bonner will oversee SCDAA’s national... Continue Reading

SCDAA Hires New Care Coordinator

  • January 9, 2019
  • Justin Bost

Tiffany Scott will serve as SCDAA’s Care Coordinator for the Health Resources Services Administration (HRSA) grant-funded Newborn Screening Follow-up Program. In... Continue Reading

CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease

  • January 4, 2019
  • Justin Bost

CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation... Continue Reading



				
Powered by DoJiggy Nonprofit Website Hosting
production0389